Friday October 22, 2021
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BPI Conference & Exhibition – HYBRID
    • |Cell & Gene Therapy US HYBRID
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

A New Generation of Generic HCP Assays

by BPI Contributor Monday, May 5, 2014  9:01 am

A New Generation of Generic HCP Assays

← Older Post

Editor’s Choice

  • BioProcess Insider

    Boehringer’s adalimumab becomes first interchangeable mAb biosimilar

  • BioProcess Insider

    Fujifilm breaks ground on 160,000 L mammalian plant in NC

  • Sponsored Content

    Cell Line Development: Accelerating Process Optimization by Combining Ambr® 15 Cell Culture with Octet® Titer Measurements

  • BioProcess Insider

    CureVac manufacturing switch-up as it shelves COVID-19 vax

  • BioProcess Insider

    How biopharma dealt with COVID: ‘We science-ed the crap out of it!’

  • Sponsored Content

    Recombinant Proteins for Cell and Gene Therapy Research: A Conversation with Shenandoah Biotechnology

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @IndependentSol4: In the latest episode of the @BioProInsider Expression Platform podcast, @GSK relates its experience of adopting a… https://t.co/ZlBo8mWRJL 2 months ago
  • Tweet Avatar RT @BioProcessIntl: Editor @Dan5tanton speaks with Sam Machour from Samsung Biologics about the rapid response by both his company and… https://t.co/tAH5P3kAeb 4 months ago
  • Tweet Avatar RT @Dan5tanton: In the latest example of pandemic-related collaboration, @Novartis is prepping to make the drug substance for Roche… https://t.co/IpIbSP7F1c 6 months ago
  • Tweet Avatar RT @Dan5tanton: As part of a “difficult decision” to halt its biosimilars programs in China, Pfizer is offloading its single-use bi… https://t.co/vsE7WAknKd 7 months ago
Follow @bioproinsider

Trending

  • Manufacturing

    eBook: Bispecific Antibodies — Their Development and Manufacture As Therapeutics

  • Manufacturing

    eBook: CAR-T Cell Therapy — Mitigating Clinical and Bioprocess Limitations

  • BioProcess Insider

    Human error at CDMO led to Moderna vaccine contamination in Japan

  • BioProcess Insider

    AstraZeneca vaccines: Further problems at Emergent but FDA okays exports

Hello

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2021 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BPI Conference & Exhibition – HYBRID
    • Cell & Gene Therapy US HYBRID
  • BioProcess International Academy
  • Events